Company: NIVFW
Filing Date: 2025-06-03
Form Type: 424B3
Source: 0001213900-25-050825
Chunk: 52

Company: NewGenIvf Group Ltd
Filing Date: 2025-06-03
Form: 424B3
Chunk 52
---
 of the size of the share incentive plan to 20% of the outstanding shares of the Company from time to time. As a result,
NewGenIvf’s expenses associated with share-based compensation may increase, which may have an adverse effect on NewGenIvf’s
results of operations. The amended share incentive plan is available as Exhibit 4.32.

To successfully market and sell its services and products in Asia-Pacific markets, NewGenIvf must address many international business risks with which NewGenIvf has limited experience.

NewGenIvf’s business is subject to risks in connection with changes in international, national and local economic and market conditions, including the effects of global financial crises, effects of terrorist acts and war and global pandemics. Such economic changes could negatively impact infertile couples’ abilities to pay for fertility treatments around the world.

NewGenIvf’s strategy is to increase its international presence in Asia-Pacific countries and its international sales are subject to a number of risks, including:

| ● | increased competition as a result of more products and procedures receiving 
 regulatory approval or otherwise free to market in international markets;   |

| ● | longer accounts receivable payment cycles and difficulties in collecting 
 accounts receivable;                                                     |

| ● | reduced or varied protection for intellectual property rights in some 
 countries;                                                            |

| ● | export restrictions, trade regulations, and foreign tax laws; |

| ● | fluctuations in currency exchange rates; |

| ● | foreign certification and regulatory clearance or approval requirements; |

| ● | customs clearance and shipping delays; |

| ● | political, social, and economic instability abroad, terrorist attacks, 
 and security concerns in general;                                      |

| ● | preference for locally provided services; |

| ● | potentially adverse tax consequences, including the complexities of 
 foreign value-added tax systems;                                    |

| ● | the burdens of complying with a wide variety of foreign laws and different 
 legal standards; and                                                       |

| ● | increased financial accounting and reporting burdens and complexities. |

If one or more of these risks are realized, its business, financial condition and results of operations could be adversely affected.

Ethical, legal and social concerns related to the use of assisted reproductive technology could reduce demand for the fertility services provided by the medical facilities in NewGenIvf’s network, and thus may adversely affect the business, financial conditions and results of operations of the medical facilities in its network.

Patient sentiment and distrust of the use of assisted reproductive technology may lead to less demand for fertility services. Assisted reproductive technologies